Novel natural product therapeutics targeting both inflammation and cancer
References (135)
- et al.
Inflammation and cancer: tissue regeneration gone awry [J]
Curr Opin Cell Biol
(2016) - et al.
NFAT as cancer target: mission possible? [J]
Biochim Biophys Acta
(2014) - et al.
MDM2 (murine double minute-2) links inflammation and tubular cell healing during acute kidney injury in mice [J]
Kidney Int
(2012) - et al.
p53-independent roles of MDM2 in NF-kappaB signaling: implications for cancer therapy, wound healing, and autoimmune diseases [J]
Neoplasia
(2012) - et al.
CREB-binding protein is a nuclear integrator of nuclear factor-kappaB and p53 signaling [J]
J Biol Chem
(1999) - et al.
MDM2 induces NF-kappaB/p65 expression transcriptionally through Sp1-binding sites: a novel, p53-independent role of MDM2 in doxorubicin resistance in acute lymphoblastic leukemia [J]
Blood
(2002) - et al.
An alternative splice form of Mdm2 induces p53-independent cell growth and tumorigenesis [J]
J Biol Chem
(2004) - et al.
Bioactive natural products in cancer prevention and therapy: Progress and promise [J]
Semin Cancer Biol
(2016) - et al.
What made sesquiterpene lactones reach cancer clinical trials? [J]
Drug Discov Today
(2010) - et al.
Parthenolide: from plant shoots to cancer roots [J]
Drug Discov Today
(2013)
Hookerolides A-D, the first naturally occurring C-17-pseudoguaianolides from Inula hookeri [J]
Tetrahedron Lett
(2013)
New sesquiterpenes from Inula japonica Thunb. with their inhibitory activities against LPS-induced NO production in RAW264.7 macrophages [J]
Tetrahedron
(2010)
Sesquiterpene lactones from Inula falconeri, a plant endemic to the Himalayas, as potential anti-inflammatory agents [J]
Eur J Med Chem
(2011)
Bioactive eudesmane and germacrane derivatives from Inula wissmanniana Hand.-Mazz [J]
Phytochemistry
(2013)
Selective cytotoxicity, inhibition of cell cycle progression, and induction of apoptosis in human breast cancer cells by sesquiterpenoids from Inula lineariifolia Turcz [J]
Eur J Med Chem
(2013)
Japonicones A-D, bioactive dimeric sesquiterpenes from Inula japonica Thunb [J]
Bioorg Med Chem Lett
(2009)
Japonicones Q-T, four new dimeric sesquiterpene lactones from Inula japonica Thunb. [J]
Fitoterapia
(2013)
Japonicone A antagonizes the activity of TNF-alpha by directly targeting this cytokine and selectively disrupting its interaction with TNF receptor-1 [J]
Biochem Pharmacol
(2012)
Artemisinin, a miracle of traditional Chinese medicine [J]
Nat Prod Rep
(2015)
Artemisinin inhibits inflammatory response via regulating NF-kappaB and MAPK signaling pathways [J]
Immunopharmacol Immunotoxicol
(2016)
The role of heme and the mitochondrion in the chemical and molecular mechanisms of mammalian cell death induced by the artemisinin antimalarials [J]
J Biol Chem
(2011)
Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis [J]
Cancer Lett
(2009)
Preclinical efficacy and safety assessment of artemisinin-chemotherapeutic agent conjugates for ovarian cancer [J]
EBioMedicine
(2016)
Immunity, inflammation, and cancer: an eternal fight between good and evil [J]
J Clin Invest
(2015)
Inflammation and cancer: advances and new agents [J]
Nat Rev Clin Oncol
(2015)
Analysis of the intricate relationship between chronic inflammation and cancer [J]
Biochem J
(2015)
The role of the mediators of inflammation in cancer development [J]
Pathol Oncol Res
(2015)
Molecular link mechanisms between inflammation and cancer [J]
Curr Pharm Des
(2012)
Chronic inflammation and cancer: suppressing the suppressors [J]
Cancer Immunol Immunother
(2014)
NF-kappaB and the link between inflammation and cancer [J]
Immunol Rev
(2012)
NF-kappaB and STAT3 signaling pathways collaboratively link inflammation to cancer [J]
Protein Cell
(2013)
NFAT gene family in inflammation and cancer [J]
Curr Mol Med
(2013)
HIF-1 at the crossroads of hypoxia, inflammation, and cancer [J]
Int J Cancer
(2016)
The MDM2-p53 pathway revisited [J]
J Biomed Res
(2013)
Natural product MDM2 inhibitors: anticancer activity and mechanisms of action [J]
Curr Med Chem
(2012)
Small-molecule MDM2- p53 inhibitors: recent advances [J]
Future Med Chem
(2015)
Recent advances of p53-MDM2 small molecule inhibitors (2011-present) [J]
Curr Med Chem
(2015)
MDM2 beyond cancer: podoptosis, development, inflammation, and tissue regeneration [J]
Histol Histopathol
(2015)
Co-expression of p53 and MDM2 in human atherosclerosis: implications for the regulation of cellularity of atherosclerotic lesions [J]
J Pathol
(1998)
Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity [J]
J Pathol
(2004)
Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease [J]
Environ Mol Mutagen
(2004)
Inhibition of MDM2 attenuates neointimal hyperplasia via suppression of vascular proliferation and inflammation [J]
Cardiovasc Res
(2011)
p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300 [J]
Cancer Res
(1998)
Transcriptional cross talk between NF-kappaB and p53 [J]
Mol Cell Biol
(1999)
Nutlin-3 inhibits the NFkappaB pathway in a p53-dependent manner: implications in lung cancer therapy [J]
Cell Cycle
(2007)
The inflammasome: an emerging therapeutic oncotarget for cancer prevention [J]
Oncotarget
(2016)
NOD-like receptors: Master regulators of inflammation and cancer [J]
Front Immunol
(2014)
Src as the link between inflammation and cancer [J]
Front Physiol
(2013)
Natural products as mechanism-based anticancer agents: Sp transcription factors as targets [J]
Phytother Res
(2016)
Natural products as sources of new drugs from 1981 to 2014 [J]
J Nat Prod
(2016)
Cited by (50)
Hedychium flavum flower essential oil: Chemical composition, anti-inflammatory activities and related mechanisms in vitro and in vivo
2023, Journal of EthnopharmacologySesquiterpenoid oligomers from chloranthaceae plants: Structural diversity, biological activities and total syntheses
2023, Studies in Natural Products Chemistry
Available online 20 Jun., 2017
[Research funding] This work was supported by NIH/NCI (Grant R01 CA186662 to R.Z.) and by American Cancer Society (Grant RSG-15-009-01-CDD to W.W.).
These authors have no conflict of interest to declare.
Copyright © 2017 China Pharmaceutical University. Published by Elsevier B.V. All rights reserved.